Eurofins Central Laboratory offers the global reach and comprehensive capabilities of a top-tier laboratory services partner while maintaining a nimble and responsive approach.
At Eurofins Central Laboratory, we foster a close-knit, collaborative work environment and maintain close relationships with clients with a strong sense of purpose and ownership. As your laboratory services provider, we encourage innovation and creative problem-solving, leading to more dynamic and effective solutions when partnering with our clients to advance therapeutic innovation.
Eurofins Central Laboratory supports:
Safety and efficacy testing
Anatomic pathology and histology
Molecular assays
Biomarker assay development and testing
Flow cytometry
Kits and logistics
Sample management services
Project management and data management services
Through our Eurofins Clinical Trial Solutions offering, Eurofins Central Laboratory seamlessly connects with other Eurofins companies to provide expertise in molecular genomics, oncology, cell & gene therapy, bioanalytical services, vaccine development, and packaging and distribution of IMP.
This approach ensures streamlined access to advanced capabilities and tailored solutions at every stage of your clinical trial - delivering efficiency, expertise, and quality from start to finish.
As part of the Eurofins network's BioPharma Services companies, the Eurofins Central Laboratory network has amassed more than 25 years of experience. Our clients benefit from the fact that we have belonged to one of the world’s leading laboratory testing networks since 2001. This means our clients enjoy end-to-end testing solutions, free from the worry of coordinating multiple vendors. Our testing capabilities are unsurpassed and we are setting new standards with our GCLP capabilities embedded within the central laboratory.
We go above and beyond to provide a myriad of services to ensure that clinical trial samples are collected, transported, managed, analyzed, reported, and stored to meet the objectives and purposes of each study, patient, and sponsor.